ARS Pharmaceuticals Inc. (SPRY)
12.69
0.20 (1.60%)
At close: Mar 31, 2025, 1:57 PM
ARS Pharmaceuticals Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 50.82M | 70.97M | 210.52M | 60.06M | 24.52M | 9.98M | 20.16M |
| Short-Term Investments | 263.2M | 157.39M | 63.86M | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | 64.78M | 350K | 550K | 750K |
| Other Long-Term Assets | 8.42M | 21K | 2.96M | -64.76M | -348K | n/a | n/a |
| Receivables | 8.18M | 795K | n/a | 1K | 384K | n/a | n/a |
| Inventory | 5.21M | n/a | -1.01M | -6.78M | -2.61M | n/a | n/a |
| Other Current Assets | 6.89M | 2.57M | 2.31M | 666K | 1.48M | 552K | 618K |
| Total Current Assets | 334.3M | 231.73M | 277.7M | 60.73M | 26.38M | 10.53M | 20.78M |
| Property-Plant & Equipment | 1.07M | 824K | 774K | 693K | 23K | 4.57M | 6.02M |
| Goodwill & Intangibles | 7.37M | 617K | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 16.86M | 1.46M | 3.73M | 716K | 25K | 5.12M | 6.77M |
| Total Assets | 351.15M | 233.19M | 281.44M | 61.45M | 26.41M | 15.65M | 27.55M |
| Account Payables | 9.87M | 759K | 1.66M | 1.79M | 1.22M | 3.52M | 775K |
| Deferred Revenue | 557K | n/a | 283K | 1.46M | 3.52M | n/a | n/a |
| Short-Term Debt | 42K | 237K | 460K | 3.62M | 2.56M | 12.3M | 3.53M |
| Other Current Liabilities | 12.97M | 1.39M | 2.87M | 1.32M | 915K | 2.11M | 841K |
| Total Current Liabilities | 23.44M | 2.39M | 5.44M | 8.19M | 8.21M | 17.93M | 5.14M |
| Long-Term Debt | n/a | 37K | 251K | 5.41M | 7.46M | 3.32M | 4.21M |
| Other Long-Term Liabilities | 70.92M | n/a | n/a | 76.12M | 27K | n/a | -1 |
| Total Long-Term Liabilities | 70.92M | 37K | 3.1M | 84.53M | 32.25M | 3.32M | 4.21M |
| Total Liabilities | 94.36M | 2.43M | 8.55M | 92.72M | 40.46M | 21.25M | 9.35M |
| Total Debt | 42K | 274K | 481K | 9.03M | 10.02M | 15.62M | 7.73M |
| Common Stock | 10K | 10K | 9K | 257K | 223K | n/a | n/a |
| Retained Earnings | -123.31M | -131.3M | -76.94M | -42.26M | -22.01M | -63.79M | -39.82M |
| Comprehensive Income | n/a | 49K | 407K | -326K | -21.23M | n/a | n/a |
| Shareholders Equity | 256.8M | 230.76M | 272.89M | -31.27M | -14.05M | -5.6M | 18.2M |
| Total Investments | 263.2M | 157.39M | 63.86M | 64.78M | 350K | 550K | 750K |